ASX:COH Cochlear (COH) Stock Forecast, Price & News Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume201,277 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.27%Price TargetN/A ProfileProfileChartCompetitorsDividendInsider TradesHeadlinesOptions ChainProfileChartCompetitorsDividendInsider TradesHeadlinesOptions Chain About Cochlear (ASX:COH) StockCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.Read More Receive COH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address COH Stock News HeadlinesMay 30, 2023 | finance.yahoo.comSome Investors May Be Worried About Cochlear's (ASX:COH) Returns On CapitalMay 13, 2023 | finance.yahoo.comCochlear Limited's (ASX:COH) largest shareholders are retail investors with 55% ownership, institutions own 45%June 3, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...April 27, 2023 | finance.yahoo.comCochlear (ASX:COH) shareholders have earned a 12% CAGR over the last three yearsApril 20, 2023 | afr.comCochlear’s UK acquisition knocked back by UK competition watchdogApril 10, 2023 | finance.yahoo.comAs Cochlear Limited (ASX:COH) hits AU$16b market cap, insiders may be dismayed about not purchasing higher quantitiesApril 9, 2023 | forbes.comCochlear Implant Companies: What To Know About Your OptionsMarch 21, 2023 | technews.tmcnet.comHearing loss in global spotlight as technology and research leaders collaborate to tackle rising impact, and experts unite to demystify careJune 3, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...February 22, 2023 | finance.yahoo.comCochlear announces audio streaming from Amazon Fire TV devices for hearing implant usersFebruary 14, 2023 | msn.comCochlear share price surges 6% on solid half and buybackFebruary 7, 2023 | msn.comWhy experts say these ASX 200 blue chip shares are buysJanuary 8, 2023 | finance.yahoo.comDo Fundamentals Have Any Role To Play In Driving Cochlear Limited's (ASX:COH) Stock Up Recently?December 20, 2022 | reuters.comUK regulator to launch deeper probe into Cochlear's takeover of Oticon MedicalDecember 16, 2022 | finance.yahoo.comCapital Allocation Trends At Cochlear (ASX:COH) Aren't IdealNovember 30, 2022 | finance.yahoo.comIndividual investors account for 52% of Cochlear Limited's (ASX:COH) ownership, while institutions account for 47%November 27, 2022 | fool.com.auAre these the ASX growth shares to buy for 2023?November 16, 2022 | finance.yahoo.comThose who invested in Cochlear (ASX:COH) five years ago are up 21%November 1, 2022 | finance.yahoo.comThe Independent Non-Executive Chairman of the Board of Cochlear Limited (ASX:COH), Catriona Deans, Just Bought 13% More SharesOctober 30, 2022 | finance.yahoo.comCochlear Limited (COH.XA)September 29, 2022 | fool.com.au3 ASX 200 companies that could benefit from a falling Aussie dollarSeptember 20, 2022 | fool.com.auWhy is the Cochlear share price slipping on Wednesday?August 21, 2022 | fool.com.auGoldman Sachs tips Cochlear share price to rise 13%August 17, 2022 | reuters.comCOH.AX - Cochlear Limited | Stock Price & Latest News | ReutersAugust 3, 2022 | fool.com.auWhy the Cochlear Limited (ASX:COH) share price bounced higher todayJune 21, 2022 | fool.com.auDown 20% in a year, is the Cochlear share price a bargain buy?June 11, 2022 | finance.yahoo.comWhat You Need To Know About Cochlear Limited's (ASX:COH) Investor CompositionSee More Headlines COH Company Calendar Last Earnings2/19/2019Ex-Dividend for 4/13 Dividend3/20/2023Dividend Payable4/13/2023Today6/03/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:COH CUSIPN/A CIKN/A Webwww.cochlear.com Phone+61-2-94286555FaxN/AEmployees4,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$3.99 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth3.87Net Income$261.40 million Net Margins15.26% Pretax MarginN/A Return on Equity15.17% Return on Assets9.09% Debt Debt-to-Equity Ratio14.60 Current Ratio2.83 Quick Ratio1.93 Sales & Book Value Annual Sales$1.71 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow123.45 Book ValueA$26.08 per share Price / BookN/AMiscellaneous Outstanding Shares65,720,000Free FloatN/AMarket CapN/A OptionableOptionable Beta0.45 Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 56)MBA, CEO, MD, Pres & Exec. Director Comp: $3.88MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 58)Chief Technology Officer Comp: $1.63MMr. Anthony BishopPres of Asia Pacific & Latin AmericaMs. Lisa AubertPres of North AmericaMr. Richard Brook MBAPres of EMEAMr. David HackshallChief Information OfficerMs. Kristina DevonVP of Investor RelationsMs. Jennifer StevensonVP of Corp. Communications & BrandMr. Dean PhizackleaSr. VP of Global Strategic MarketingMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAllegra OrthopaedicsASX:AMTAnalyticaASX:ALTAnteoTechASX:ADOView All CompetitorsInsidersMichael del PradoBought 132 shares on 3/6/2023Total: $19,876.96 ($150.58/share)Michael del PradoBought 150 shares on 11/1/2022Total: $19,200.00 ($128.00/share)Catriona DeansBought 500 shares on 10/26/2022Total: $97,485.00 ($194.97/share)Karen PenroseBought 128 shares on 10/24/2022Total: $24,960.00 ($195.00/share)Dig HowittSold 19,087 sharesTotal: $3.84 M ($201.34/share)View All Insider Transactions COH Stock - Frequently Asked Questions How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) released its quarterly earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. Cochlear had a net margin of 15.26% and a trailing twelve-month return on equity of 15.17%. How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear declared a Interim dividend on Thursday, March 16th. Shareholders of record on Thursday, April 13th will be given a dividend of 1.55 per share on Thursday, April 13th. This represents a yield of 0.67%. The ex-dividend date of this dividend is Monday, March 20th. Read our dividend analysis for COH. Is Cochlear a good dividend stock? Cochlear (ASX:COH) pays an annual dividend of A$3.10 per share and currently has a dividend yield of 1.27%. The dividend payout ratio is 77.69%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for COH. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto Group (RIO), Altium (ALU), Abbott Laboratories (ABT), Afterpay (APT), Appen (APX), Cross Timbers Royalty Trust (CRT) and Janus Henderson Group (HGG). What is Cochlear's stock symbol? Cochlear trades on the ASX under the ticker symbol "COH." How much money does Cochlear make? Cochlear (ASX:COH) has a market capitalization of $0.00 and generates $1.71 billion in revenue each year. The company earns $261.40 million in net income (profit) each year or A$3.99 on an earnings per share basis. How many employees does Cochlear have? The company employs 4,000 workers across the globe. How can I contact Cochlear? Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The official website for the company is www.cochlear.com. The company can be reached via phone at +61-2-94286555. This page (ASX:COH) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.